Abstract
The paper presents the case of clinical observation of a patient with atypical hemolytic-uremic syndrome (aHUS). aHUS is a disease characterized by an unfavorable prognosis (severe or catastrophic course with rapid development of terminal renal or multi-organ failure). The aim of the study is to evaluate the approaches to differential diagnosis of aHUS in clinical practice. Material and methods. The study was conducted on the basis of the Nephrology Department of Kemerovo Regional Clinical Hospital n.a. S.V Belyaev. The clinical observation of patient D., aged 26 years old, is discussed. Results and discussion. Diagnosing aHUS requires: 1) diagnosing thrombotic microangiopathy (TMA: thrombocytopenia or decrease in platelet count by more than 25 % of original, visceral damage (kidneys, CNS, gastrointestinal tract, heart, lungs)); 2) ruling out HUS associated with Shiga toxin-producing Escherichia coli (STEC-HUS; negative for Shiga-toxin in blood and stool), thrombotic thrombocytopenic purpura (TTP), systemic connective tissue disease, catastrophic antiphospholipid syndrome, HIV infection; 3) assessing the activity of ADAMTS13 (decrease confirms the aHUS diagnosis); 4) proving normal content of complement components C3 and C4 as an additional argument in favor of aHUS diagnosis. At the first stage, the patient was diagnosed with TMA (platelet content 37 x 10 9 / l , hemoglobin content 59 g/l), LDH up to 824 E/l), liver damage (AST, ALT and LDH activity 55, 60 and 824 U/l, respectively), kidney damage (acute renal damage), lungs, heart, and brain damage. At the second stage the following diagnoses were ruled out: STEC-HUS (Shiga toxin in blood and stool was not detected), TTP (ADAMTS13 activity level was 66 %, whereas reference values are 93-113 %, in TTP - below 5-10 %); systemic connective tissue diseases catastrophic antiphospholipid syndrome, HIV infection sepsis. Normal values of C3 (0.9 g/l) and C4 (0.23 g/l) complement components did not rule out the diagnosis of aHUS.
Highlights
NatalyaViktorovna FOMINA1,2, Lyudmila Daniilovna CHESNOKOVA1,2, Olga Alexandrovna KONDEROVA1, Svetlana Anatolevna SMAKOTINA1,2, Ekaterina Vladimirovna UTKINA2, Vladislav Yuryevich ISAEV2
The paper presents the case of clinical observation of a patient with atypical hemolytic-uremic syndrome. aHUS is a disease characterized by an unfavorable prognosis
The aim of the study is to evaluate the approaches to differential diagnosis of aHUS in clinical practice
Summary
NatalyaViktorovna FOMINA1,2, Lyudmila Daniilovna CHESNOKOVA1,2, Olga Alexandrovna KONDEROVA1, Svetlana Anatolevna SMAKOTINA1,2, Ekaterina Vladimirovna UTKINA2, Vladislav Yuryevich ISAEV2. The paper presents the case of clinical observation of a patient with atypical hemolytic-uremic syndrome (aHUS). At the second stage the following diagnoses were ruled out: STEC-HUS (Shiga toxin in blood and stool was not detected), TTP (ADAMTS13 activity level was 66 %, whereas reference values are 93–113 %, in TTP – below 5–10 %); systemic connective tissue diseases catastrophic antiphospholipid syndrome, HIV infection sepsis. Correspondence author: Utkina E.V., e-mail: Goll1997.2011@mail.ru Citation: Fomina N.V., Chesnokova L.D., Konderova O.A., Smakotina S.A., Utkina E.V., Isaev V.Yu. Difficulties in diagnosing atypical hemolytic uremic syndrome. Цель настоящего исследования – оценить подходы дифференциальной диагностики аГУС в клинической практике врача
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.